Cleerly COMPARE
Measure. Modify. Manage.

Assess plaque and help guide treatment. All with one AI-powered solution.

Request a demo

Why Cleerly COMPARE?

Cleerly COMPARE is a revolutionary feature that empowers physicians to evaluate changes to coronary artery disease (CAD) and helps guide therapeutic decisions to achieve key treatment goals.

cleerly-website_compare_icons_assess-changes

Assess changes in plaque over time

Cleerly COMPARE provides longitudinal disease evaluation so providers can assess changes in CAD progression — key to heart attack prevention

cleerly-website_compare_icons_personalized-treatment

Guide personalized treatment

The report from Cleerly COMPARE helps inform treatment decisions, allowing you to individualize therapy to specific patient needs

cleerly-website_compare_icons_human-refined

Human-refined

The AI-generated report is reviewed, refined, and confirmed by a human reviewer to ensure that you’re working with the precise, consistent analysis data

AI-generated. Human-refined.

The AI-generated report is reviewed, refined, and confirmed by a human reviewer to ensure that you’re working with the precise, consistent analysis data.

Taking the Cleerly AI-generated report further with a personalized expert reviewer. Included with the Cleerly COMPARE feature is an added level of analysis by a human reviewer. There is no extra cost for this additional level of review.

From plaque analysis to lifestyle optimization

  • Evaluation and monitoring of plaque, including low-density-non-calcified plaque, non-calcified plaque, and calcified plaque, can help physicians assess a patient’s risk above and beyond stenosis severity and aggregate plaque burden1
  • Clinically relevant insights provide a framework for physicians to initiate, intensify, or de-intensify medical management of patients with CAD2

cleerly-website_compare_41-percent

reduction in the rate of death and non-fatal heart attacks in patients with chest pain that receive a CCTA vs patients that did not at 5 years3

Assessing atherosclerosis is challenging due to limitations of current image processing4

cleerly-plaque-assessing
 

The information display of Cleerly COMPARE allows you to easily compare results from one CCTA to the next, with an unprecedented level of detail

compare-ui-progression-case-v2

Evaluate plaque volume from scan to scan

compare-ui-plaque-regression-v2

In some cases, plaque may regress between scans, indicating that the patient's therapy is effective

Cleerly Compare

Analyze in lesion-by-lesion detail

Request your Cleerly demo

Contact us for a one-on-one software demonstration with a Cleerly expert to see how bringing Cleerly’s AI‑driven CCTA analysis to your organization can empower you to provide personalized treatment decisions for your patients.

Request a Demo